Đang chuẩn bị liên kết để tải về tài liệu:
Malignant pleural mesothelioma: Treatment patterns and humanistic burden of disease in Europe

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Malignant pleural mesothelioma (MPM) is an aggressive and rare tumour with poor prognosis. Most patients are diagnosed with advanced disease and there is a paucity of data on the humanistic burden of MPM in terms of impact on health-related quality of life (HRQoL) and activity. |

TÀI LIỆU LIÊN QUAN

Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

Serum levels of the chemokine CCL2 are elevated in malignant pleural mesothelioma patients

Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: A cohort study

Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma

Malignant pleural mesothelioma: diagnostic value of medical thoracoscopy and longterm prognostic analysis

Biomarkers for predicting malignant pleural mesothelioma in a Mexican population

Physician requests by patients with malignant pleural mesothelioma in Japan

CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure

Systematic review of quality of life following pleurectomy decortication and extrapleural pneumonectomy for malignant pleural mesothelioma

Quality of life of survivors of malignant pleural mesothelioma in Japan: A cross sectional study
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.